Related Experiment Video
Updated: Dec 27, 2025
08:33
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
1.6K
Current and Emerging Pharmacotherapy for Fibromyalgia
1Department of Internal Medicine H, Tel Aviv Sourasky Medical Centre and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pain Research & Management
|February 28, 2020
Summary
Fibromyalgia syndrome (FMS) is a complex pain disorder impacting 1-5% of people. Current treatments are limited, necessitating research into new therapies like cannabinoids and opioids for personalized FMS management.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Medicine
Background:
- Fibromyalgia syndrome (FMS) is a chronic pain disorder with a 1-5% prevalence.
- Pathogenesis involves neural oversensitization, impaired pain modulation, and cognitive dysfunction.
- Increased brain connectivity in pain, alertness, and cognition pathways complicates pharmacologic treatment.
Purpose of the Study:
- To review current pharmacologic treatments for fibromyalgia.
- To discuss future therapeutic perspectives for FMS.
Main Methods:
- Literature review of clinical experience with fibromyalgia pharmacotherapies.
- Analysis of emerging research in pain management and central nervous system disorders.
Main Results:
- Current FDA-approved FMS medications include pregabalin, duloxetine, and milnacipran.
- Numerous other agents have shown variable efficacy.
- Understanding FMS pathogenesis is key to developing effective treatments.
Conclusions:
- Future FMS therapies may involve cannabinoid and opioid research.
- An integrative approach combining genetics, functional imaging, and CNS research is promising.
- Novel, personalized treatments for FMS patients are anticipated.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
705
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
705
01:28Drug Therapy
202
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
202
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
826
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
826
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.2K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.2K
01:25Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
4.3K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.3K